Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/1995
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172287A1 Nf-at polypeptides and polynucleotides
03/30/1995CA2172147A1 2',5'-oligoadenylate-2',3'-cyclophosphates
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/29/1995EP0644939A1 Protein kinase c (iota)
03/29/1995EP0644933A1 Constitutive and inducible epidermal vector systems
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644890A1 Oligonucleotide-polyamide conjugates
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995CN1100728A Nucleosides and oligonucleotides having 2'-ether groups
03/28/1995US5401847 DNA complexes with dyes designed for energy transfer as fluorescent markers
03/28/1995US5401837 Method for labeling the 3' terminus of a synthetic oligonucleotide using a unique multifunctional controlled pore glass (MF-CPG) reagent in solid phase oligonucleotide synthesis
03/23/1995WO1995008003A1 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007992A2 Cloned glutamic acid decarboxylase
03/23/1995WO1995007988A1 PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME
03/23/1995WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007924A1 Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007918A2 Pyrimidine derivatives for labeled binding partners
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995WO1995003333A3 Tryptase inhibitor
03/23/1995DE4331670A1 Antisense oligonucleotides against HSV-1 and the preparation thereof
03/23/1995CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2171288A1 Purified ph neutral rhizoctonia laccases and nucleic acids encoding same
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995CA2169535A1 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
03/22/1995EP0644196A1 TTTr as a protecting group in nucleotide synthesis
03/22/1995EP0643974A1 Vaccine against lyme disease
03/22/1995EP0643778A1 Encoded combinatorial chemical libraries
03/22/1995EP0643768A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
03/22/1995EP0643721A1 Method of synthesizing sulfurized oligonucleotide analogs
03/22/1995EP0643720A1 Binding competent oligomers containing 2', 5' linkages
03/22/1995EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
03/22/1995EP0643559A1 Diphtheria toxin receptor-binding region
03/22/1995CN1100272A Composition and process for enhancing the pre-adult growth and feed conversion efficiency of a porcine animal
03/21/1995US5399681 Alkylation with ethyleneimine, rearrangement, bonding to polymer or macromolecule solid support
03/18/1995CA2132133A1 Tttr as protective group in nucleotide synthesis
03/16/1995WO1995007364A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
03/16/1995WO1995007289A1 Nucleic acid probes for lactobacillus detection
03/16/1995WO1995007288A1 Antiretroviral substance prohibicin and microorganism producing the same
03/16/1995WO1995007088A1 RECOMBINANT α-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995004151A3 Vaccine compositions containing recombinant tetc-fusion proteins
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995002051A3 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995WO1994024144A3 Enhanced triple-helix and double-helix formation with oligomers containing modified purines
03/16/1995CA2169536A1 Nucleic acid ligands and improved methods for producing the same
03/15/1995EP0643076A1 Novel peptide having receptor activity and dna coding for said peptide
03/15/1995EP0642761A1 Method of quantitative determination of bone salt with ct equipment
03/15/1995EP0642592A1 Ligase chain reaction starting with rna sequences
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids
03/15/1995EP0642580A1 Hepatocyte growth factor variants
03/15/1995EP0642524A1 Systemin
03/14/1995CA2106015A1 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences
03/09/1995WO1995006764A2 Oligonucleotides with rna cleavage activity
03/09/1995WO1995006756A2 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS)
03/09/1995WO1995006755A1 Nucleic acid probes to mycobacterium avium complex
03/09/1995WO1995006751A1 Methods for isolation of most abundant oligonucleotides from complex mixtures
03/09/1995WO1995006749A1 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(NEISSERIA GONORRHOEAE)
03/09/1995WO1995006734A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995WO1995006731A2 Non-nucleotide containing enzymatic nucleic acid
03/09/1995WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995WO1995006726A2 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006718A2 Methods of suppressing autoimmune response
03/09/1995WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
03/09/1995WO1995006659A1 Amine-derivatized nucleosides and oligonucleosides
03/09/1995WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1995002704A3 Poliovirus specific primers and methods of detection utilizing the same
03/09/1995DE4328637A1 Process for the synthesis and selection of sequences of covalently linked building blocks
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170899A1 Nucleic acid probes to mycobacterium avium complex
03/09/1995CA2170871A1 Oligonucleotides and methods for the detection of neisseria gonorrhoeae
03/09/1995CA2170725A1 Gene serum opacity factor
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2170148A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995CA2169645A1 Non-nucleotide containing enzymatic nucleic acid
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2158932A1 Methods of suppressing autoimmune response
03/08/1995EP0641354A1 Oligonucleotides having aminohydrocarbon phosphonate moieties
03/08/1995EP0641353A1 Anti-sense oligonucleotides for isotype-specific suppression of immunoglobulin production
03/08/1995EP0641215A1 Protease-resistant thrombomodulin analogs
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/08/1995CN1099802A Tumor necrosis factor muteins
03/07/1995US5395928 Elution with controlled concentration of buffer with soft base counterion
03/07/1995US5395924 Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
1 ... 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 ... 899